<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The t(11;14)(q13;q32) is a chromosomal abnormality usually associated with mantle cell (centrocytic) <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, although it has occasionally been reported in other <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0005523'>lymphoproliferative disorders</z:hpo> such as <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo>, prolymphocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo>, splenic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> with villous lymphocytes, and <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>This abnormality results in the translocation of the bcl-1 oncogene from chromosome 11 to the immunoglobulin heavy chain locus on chromosome 14 </plain></SENT>
<SENT sid="2" pm="."><plain>The bcl-1 oncogene is a member of the cyclin gene family, and high levels of cyclin D1 <z:chebi fb="2" ids="33699">mRNA</z:chebi> are consistently found in malignant B cell proliferations with t(11;14) </plain></SENT>
<SENT sid="3" pm="."><plain>PATIENTS AND METHODS: We examined cyclin D1 protein expression in 33 patients with low grade <z:hpo ids='HP_0005523'>lymphoproliferative disorders</z:hpo> and 2 patients with reactive <z:mpath ids='MPATH_134'>hyperplasias</z:mpath> by Western blot analysis using a polyclonal antibody </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: 8/11 mantle cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, 0/11 <z:hpo ids='HP_0005550'>chronic lymphocytic leukemias</z:hpo>, 0/4 hairy cell <z:hpo ids='HP_0001909'>leukemias</z:hpo>, 0/2 Sezary syndrome, 0/2 monocytoid B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, 0/3 follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, and 0/2 reactive <z:mpath ids='MPATH_134'>hyperplasias</z:mpath> had overexpression of cyclin D1 </plain></SENT>
<SENT sid="5" pm="."><plain>Cytogenetic analysis was performed in four cases of mantle cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>; three of these cases had the t(11;14), one of which was hypotetraploid with two copies of t(11;14) </plain></SENT>
<SENT sid="6" pm="."><plain>Immunophenotypically, <z:hpo ids='HP_0000001'>all</z:hpo> cases of mantle cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo> had coexpression of CD5 and CD20 </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: Mantle cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> may be difficult to discriminate from <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo>, a more indolent disease, on morphologic and immunophenotypic grounds </plain></SENT>
<SENT sid="8" pm="."><plain>Our findings suggest that analysis of cyclin D1 protein expression may be helpful in differentiating mantle cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> from other low grade <z:hpo ids='HP_0005523'>lymphoproliferative disorders</z:hpo> </plain></SENT>
</text></document>